Olverembatinib Improves EFS in TKI-Resistant Chronic Phase CML
Cancer Therapy Advisor » Chronic Myeloid Leukemia
by
7M ago
Olverembatinib improved event-free survival over best available therapy in patients with TKI-resistant chronic phase CML in a phase 2 trial ..read more
Visit website
Lower-Dose Ponatinib Appears Effective as Induction in Chronic Phase CML
Cancer Therapy Advisor » Chronic Myeloid Leukemia
by
7M ago
Lower-dose ponatinib has demonstrated efficacy as induction in patients with chronic phase chronic myeloid leukemia in a phase 2 trial ..read more
Visit website
Oncology Drug Coverage Determination Takes Months
Cancer Therapy Advisor » Chronic Myeloid Leukemia
by
9M ago
Coverage determination for oncology drugs can be delayed for months after regulatory approval, a new study suggests ..read more
Visit website
OS Benefits of TKIs Less Likely Among Lower-Income Patients With Ph+ CML
Cancer Therapy Advisor » Chronic Myeloid Leukemia
by
9M ago
Among US patients with Ph+ CML, those with lower incomes have not derived the same benefits from therapeutic advances as those with higher incomes ..read more
Visit website
Bosulif Approved for Pediatric Patients With Chronic Phase Ph+ CML
Cancer Therapy Advisor » Chronic Myeloid Leukemia
by
10M ago
The FDA has approved bosulif (bosutinib) for patients aged 1 year or older with chronic phase Ph+ CML ..read more
Visit website
Breakthroughs in Targeted Therapy, Immunotherapy Reduce Cancer Deaths
Cancer Therapy Advisor » Chronic Myeloid Leukemia
by
10M ago
Breakthroughs in targeted therapy and immunotherapy are partly responsible for the recent decline in US cancer deaths, according to the AACR Cancer Progress Report 2023 ..read more
Visit website
Systemic Therapies May Increase Risk of VTE in Patients With Cancer and COVID-19
Cancer Therapy Advisor » Chronic Myeloid Leukemia
by
11M ago
Researchers found a higher risk of VTE in patients with cancer and COVID-19 who were receiving systemic cancer therapies ..read more
Visit website
Nilotinib Linked to Higher Risk of Diabetes, Hyperlipidemia in CML Patients
Cancer Therapy Advisor » Chronic Myeloid Leukemia
by
11M ago
Chronic myeloid leukemia patients treated with nilotinib instead of other tyrosine kinase inhibitors may have a greater risk of developing diabetes and hyperlipidemia ..read more
Visit website
Deaths Among Cancer Patients Increased During the First 2 Years of the COVID-19 Pandemic
Cancer Therapy Advisor » Chronic Myeloid Leukemia
by
11M ago
Deaths in patients with COVID-19 and cancer made up 81% of excess deaths among cancer patients during the first 2 years of the pandemic ..read more
Visit website
Cancer Survivors With Functional Disabilities Have Higher Health Care Costs
Cancer Therapy Advisor » Chronic Myeloid Leukemia
by
11M ago
Cancer survivors with functional disabilities have higher health care usage and medical costs than survivors without disabilities, data suggest ..read more
Visit website

Follow Cancer Therapy Advisor » Chronic Myeloid Leukemia on FeedSpot

Continue with Google
Continue with Apple
OR